{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":6,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":6,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"e9ba3189121d","filters":{"venue":"Clinical Prostate Cancer"}},"results":[{"id":"W2142606098","doi":"10.3816/cgc.2003.n.018","title":"Salvage Cryosurgery for Recurrent Prostate Cancer After Radiation Therapy: A Seven-Year Follow-up","year":2003,"lang":"en","type":"article","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryosurgery; Prostate cancer; Radiation therapy; Cryoablation; Prostate; Urology; Prostate-specific antigen; Cancer; Surgery; Internal medicine","authors":[{"name":"Duke Bahn","is_ca":false},{"name":"Fred Lee","is_ca":false},{"name":"Paul Silverman","is_ca":false},{"name":"Eric D. Bahn","is_ca":false},{"name":"Robert A. Badalament","is_ca":false},{"name":"Anil Kumar","is_ca":false},{"name":"Jeffrey Greski","is_ca":false},{"name":"John C. Rewcastle","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05578848116549954,"gpt":0.3793201374604634,"spread":0.3235316562949638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009548849,0.0004962779,0.0009753464,0.000112655,0.0001533809,0.00007625325,0.0001036307,0.0002188308,0.000824918],"category_scores_gemma":[0.0003978531,0.0003885942,0.0006556279,0.000342933,0.0002014688,0.0002192216,0.00003379737,0.000415912,0.00005186565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006154673,"about_ca_system_score_gemma":0.001162752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006436805,"about_ca_topic_score_gemma":0.0001001486,"domain_scores_codex":[0.9962759,0.000209253,0.001199766,0.001053837,0.0004073052,0.0008539375],"domain_scores_gemma":[0.9975472,0.0004610514,0.000433682,0.0005772048,0.0004572522,0.0005236295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01077607,0.0009302356,0.5969765,0.0003166808,0.0007016512,0.00004826569,0.0009448069,0.00001544297,0.00007616119,0.00008684581,0.03788669,0.3512406],"study_design_scores_gemma":[0.02382427,0.002973303,0.1966823,0.0008420985,0.0005070216,0.000005744905,0.0001307137,0.00005290558,0.003525336,0.000911469,0.7697982,0.0007465999],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9245268,0.057519,0.00002919593,0.005383736,0.00539424,0.005564215,0.001131467,0.0001539395,0.0002974337],"genre_scores_gemma":[0.8574519,0.1176752,0.0003195044,0.00619466,0.0008297234,0.01297569,0.0002072617,0.0001603005,0.00418578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7319115,"threshold_uncertainty_score":0.9998566,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030339269","doi":"10.3816/cgc.2005.n.009","title":"Clinical Benefit of Zoledronic Acid for the Prevention of Skeletal Complications in Advanced Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Prostate Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Bone pain; Internal medicine; Incidence (geometry); Placebo; Pathologic fracture; Oncology; Cancer; Surgery; Urology; Pathology","authors":[{"name":"Fred Saad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07892006890509327,"gpt":0.4796531205865005,"spread":0.4007330516814072,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008101013,0.0001618786,0.0006740463,0.00004868874,0.00006312781,0.000003648927,0.0001236954,0.0001440707,0.00007771554],"category_scores_gemma":[0.0002449178,0.0001123207,0.000328354,0.0002147391,0.0003268633,0.00009412587,0.00004095263,0.0003504015,0.000007870466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001425538,"about_ca_system_score_gemma":0.0007009117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000174837,"about_ca_topic_score_gemma":0.001766492,"domain_scores_codex":[0.9971678,0.00007607621,0.001814455,0.0003985133,0.0001909856,0.0003521511],"domain_scores_gemma":[0.9978259,0.0005734098,0.0006624259,0.0004355701,0.0003252036,0.0001775155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001698384,0.00106937,0.4272657,0.0002724989,0.0001453707,6.056246e-7,0.0001204518,0.0002418406,0.00009764799,0.0001232138,0.0003085676,0.5686563],"study_design_scores_gemma":[0.01269139,0.001486802,0.9546622,0.0006462718,0.0003038285,0.000001664992,0.0000516152,0.001281292,0.0006236604,0.0006654831,0.02745306,0.0001327181],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760234,0.01014405,0.00007485237,0.009226074,0.0003749771,0.003696149,0.000317681,0.00002244093,0.0001203104],"genre_scores_gemma":[0.9801851,0.01451823,0.001321799,0.0008074747,0.0001432207,0.001532294,0.00006574716,0.00002996172,0.001396185],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5685236,"threshold_uncertainty_score":0.4580306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086066681","doi":"10.3816/cgc.2002.n.016","title":"Zoledronic Acid Significantly Reduces Pathologic Fractures in Patients with Advanced-Stage Prostate Cancer Metastatic to Bone","year":2002,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Osteonecrosis of the jaw; Bisphosphonate; Bone pain; Internal medicine; Cancer; Oncology; Osteoporosis; Surgery; Urology","authors":[{"name":"Fred Saad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08720358540906437,"gpt":0.4507000596078193,"spread":0.363496474198755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006445047,0.001193575,0.004929754,0.0003839016,0.0001376716,0.00005156896,0.0002825334,0.0004814847,0.0006842889],"category_scores_gemma":[0.0003766741,0.0007497445,0.0005446292,0.001010832,0.0003104072,0.000195235,0.00012776,0.001935602,0.0002143977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058489,"about_ca_system_score_gemma":0.002079183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001739766,"about_ca_topic_score_gemma":0.0003613163,"domain_scores_codex":[0.9925289,0.0005215433,0.002849741,0.001886507,0.000750188,0.001463166],"domain_scores_gemma":[0.9958161,0.0003628965,0.001466753,0.0009243122,0.000322203,0.001107697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00164311,0.001372222,0.01690029,0.01016037,0.0004172924,0.000755958,0.0002119772,0.00002844745,2.546453e-7,0.000001124976,0.000907282,0.9676017],"study_design_scores_gemma":[0.01130613,0.005314867,0.02525321,0.03320083,0.002826086,0.00001596102,0.00004583952,0.000003826509,0.000006801964,0.00001963194,0.920729,0.001277788],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05895414,0.9272231,0.000001080439,0.0004903919,0.0007422942,0.01049568,0.001870996,0.0001160459,0.000106288],"genre_scores_gemma":[0.01056108,0.9768838,0.0005505491,0.001874818,0.0001411078,0.005809966,0.0005875068,0.0002419436,0.003349246],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9663239,"threshold_uncertainty_score":0.9994953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011246519","doi":"10.3816/cgc.2005.n.002","title":"Combined Androgen Blockade: The Case for Bicalutamide","year":2005,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Bicalutamide; Antiandrogen; Flutamide; Medicine; Prostate cancer; Castration; Urology; Antiandrogens; Internal medicine; Enzalutamide; Androgen; Oncology; Androgen receptor; Hazard ratio; Androgen deprivation therapy; Randomized controlled trial; Testosterone (patch); Combination therapy; Endocrinology; Cancer; Hormone; Confidence interval","authors":[{"name":"Laurence Klotz","is_ca":true},{"name":"Paul Schellhammer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2358887684497332,"gpt":0.5315328612553668,"spread":0.2956440928056336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001305625,0.0006393914,0.002771359,0.0001200826,0.0003188372,0.0000802873,0.0003506386,0.0006427275,0.0003517916],"category_scores_gemma":[0.0004863548,0.0003235046,0.001685906,0.000460353,0.0007295265,0.00006076534,0.0001903803,0.001376356,0.0001347366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000473576,"about_ca_system_score_gemma":0.002249327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003486376,"about_ca_topic_score_gemma":0.00003767591,"domain_scores_codex":[0.9958071,0.0003255534,0.001693564,0.0009863625,0.0003280265,0.0008593646],"domain_scores_gemma":[0.9956493,0.00199711,0.0005054353,0.0009652798,0.0003267177,0.0005561389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005929527,0.0002878412,0.00008834898,0.008715816,0.001085087,0.001409412,0.00003433693,4.228178e-7,9.215839e-8,0.00002360431,0.0210102,0.9667519],"study_design_scores_gemma":[0.00430902,0.0009044581,0.000008440867,0.005608922,0.00400704,0.0006944232,0.00002520036,0.00003920311,0.000002655154,0.00008097252,0.9839464,0.0003732758],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001753705,0.9849582,0.000004904529,0.003874766,0.0008373885,0.008707707,0.001077102,0.0001026139,0.0002619188],"genre_scores_gemma":[0.00004122584,0.9750699,0.0001285909,0.0007009737,0.002458666,0.004404494,0.0004463356,0.0001699103,0.01657991],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9663786,"threshold_uncertainty_score":0.9999217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001143432","doi":"10.3816/cgc.2003.n.017","title":"Active Surveillance with Selective Delayed Intervention: A Biologically Nuanced Approach to Favorable-Risk Prostate Cancer","year":2003,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Watchful waiting; Medicine; Prostate cancer; Disease; Intervention (counseling); Internal medicine; Prostate-specific antigen; Oncology; Cancer; Intensive care medicine","authors":[{"name":"Laurence Klotz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08358071807234146,"gpt":0.4218320146886531,"spread":0.3382512966163116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001382268,0.001656438,0.005900836,0.0002628131,0.0002945494,0.0001306571,0.0004588589,0.0008633755,0.000231623],"category_scores_gemma":[0.0004465939,0.001040866,0.001557264,0.001824205,0.0005683666,0.0001879064,0.0002132697,0.002332882,0.0001074969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00244441,"about_ca_system_score_gemma":0.003112934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005294241,"about_ca_topic_score_gemma":0.000335365,"domain_scores_codex":[0.9905552,0.001316576,0.002878613,0.003111984,0.0006696778,0.001468009],"domain_scores_gemma":[0.9932452,0.0008632211,0.002376906,0.001176526,0.001222206,0.00111588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00425237,0.002105199,0.01339468,0.006627725,0.005271056,0.000106765,0.0002881422,0.00007768082,3.148976e-7,0.00002105549,0.005537692,0.9623173],"study_design_scores_gemma":[0.00694521,0.006737856,0.003274394,0.02028475,0.003926127,0.00006406656,0.0001100735,0.00001350766,0.00001512645,0.00006432307,0.9570087,0.001555906],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001967281,0.9759401,0.0001499746,0.0003263159,0.0009867406,0.01363193,0.005228048,0.000240345,0.001529232],"genre_scores_gemma":[0.001115592,0.9693047,0.001299315,0.0009830052,0.0005218734,0.02262988,0.0009990882,0.0002966202,0.002849936],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9607614,"threshold_uncertainty_score":0.9999688,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021847075","doi":"10.1016/s1540-0352(11)70082-8","title":"Role of Magnetic Resonance Spectroscopic Imaging in the Prediction of Treatment Outcome in Prostate Cancer","year":2004,"lang":"en","type":"letter","venue":"Clinical Prostate Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Medicine; Magnetic resonance imaging; Nuclear medicine; Prostate cancer; Effective diffusion coefficient; Prostate; Standard deviation; Rectum; Flip angle; Radiology; Cancer; Internal medicine; Mathematics","authors":[{"name":"Tedros Bezabeh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04778675804492902,"gpt":0.3836048825484688,"spread":0.3358181245035398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006682564,0.000521133,0.001606665,0.0002922822,0.00002855888,0.00001736982,0.000349841,0.000416122,0.0003785452],"category_scores_gemma":[0.0001346894,0.00037209,0.00035762,0.0006006201,0.0005860321,0.00009538549,0.00006751498,0.001920351,0.000007843189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002315077,"about_ca_system_score_gemma":0.001708756,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007028084,"about_ca_topic_score_gemma":0.001302405,"domain_scores_codex":[0.9948941,0.0003095249,0.002517161,0.0009452353,0.0006298344,0.0007041337],"domain_scores_gemma":[0.9973903,0.0005635141,0.000837362,0.0009351426,0.0001919315,0.00008177945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004572259,0.0003668709,0.9297188,0.0009401967,0.00004272406,0.0001761843,0.001179654,0.00009755546,0.0001043012,0.000004004118,0.04101978,0.0258927],"study_design_scores_gemma":[0.00757914,0.001773169,0.6616432,0.004920345,0.0004048111,0.000008929662,0.0001619322,0.00009361683,0.0005854565,0.0005632091,0.3219487,0.0003174742],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3799061,0.09176697,7.9432e-7,0.5169854,0.001616717,0.006809695,0.002074204,0.00005555619,0.0007845192],"genre_scores_gemma":[0.3883591,0.3001785,0.0003915962,0.289298,0.005690619,0.01042289,0.0005507594,0.000403743,0.004704834],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.2809289,"threshold_uncertainty_score":0.9998731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}